401.0K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,666,000 | 2,165,998 | - | 2.4 | 3,998,400 | Common Stock |
| Baiteng Zhao | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,250,000 | 1,250,000 | - | 2.4 | 3,000,000 | Common Stock |
| Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,561,000 | 3,410,402 | - | 2.4 | 3,746,400 | Common Stock |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,750 | 26,750 | - | - | Common Stock | |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 2,806 | 23,944 | - | 2.3 | 6,594 | Common Stock |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,750 | 20,250 | - | - | Restricted Stock Units | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 39,119 | - | - | Common Stock | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 5,690 | 33,429 | - | 2.4 | 13,372 | Common Stock |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 48,750 | - | - | Restricted Stock Units | |
| Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 105,000 | - | - | Common Stock | |
| Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 2,147 | 102,853 | - | 2.3 | 5,045 | Common Stock |
| Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 01 Mar 2025 | 100,000 | 202,853 | - | 2.4 | 240,000 | Common Stock |
| Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 15,000 | - | - | Restricted Stock Units | |
| Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 8,333,000 | 8,333,000 | - | - | Pre-funded Warrant (right to buy) | |
| Zhao Baiteng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 61,192 | 61,192 | - | - | Stock Option (right to buy) | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 0 | - | - | Restricted Stock Units | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 32,558 | - | 0 | Common Stock | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 02 Oct 2024 | 9,689 | 22,869 | - | 1.9 | 18,797 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 03 Sep 2024 | 40,000 | 1,171,543 | - | 1.7 | 68,316 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 01 Aug 2024 | 5,652 | 1,211,543 | - | 1.3 | 7,595 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 01 Aug 2024 | 18,933 | 1,217,195 | - | 1.4 | 26,705 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 01 Aug 2024 | 15,415 | 1,236,128 | - | 1.5 | 23,055 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 01 Jul 2024 | 8,652 | 1,251,543 | - | 1.3 | 11,612 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.45 per share. | 01 Jul 2024 | 31,348 | 1,260,195 | - | 1.5 | 45,605 | Common Stock |
| Richard E. Maroun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Karin M. Hehenberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Mohammad Hirmand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,832 | 45,832 | - | - | Stock Option (right to buy) | |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 03 Jun 2024 | 20,225 | 1,291,543 | - | 1.8 | 35,746 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 03 Jun 2024 | 19,775 | 1,311,768 | - | 1.8 | 35,765 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.93 per share. | 01 May 2024 | 40,000 | 1,331,543 | - | 1.9 | 77,184 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 01 Apr 2024 | 17,772 | 1,393,771 | - | 2.3 | 41,101 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 01 Apr 2024 | 22,228 | 1,371,543 | - | 2.2 | 49,513 | Common Stock |
| Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 76,813 | 76,813 | - | - | Stock option (right to buy) | |
| Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 01 Mar 2024 | 27,036 | 1,426,507 | - | 2.0 | 53,226 | Common Stock |
| Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 01 Mar 2024 | 14,964 | 1,411,543 | - | 2.1 | 31,415 | Common Stock |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 138,263 | 138,263 | - | - | Stock Option (right to buy) | |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Scott Giacobello | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 27,000 | 27,000 | - | - | Restricted Stock Units | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 65,000 | 65,000 | - | - | Restricted Stock Units | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,768 | 30,768 | - | - | Stock option (right to buy) | |
| David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| P. Neil Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 01 Feb 2024 | 42,000 | 1,453,543 | - | 1.7 | 73,269 | Common Stock |
| Neil Desai P. | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 02 Jan 2024 | 42,000 | 1,495,543 | - | 2.1 | 86,549 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 4.82 per share. | 06 Dec 2023 | 7,037 | 1,537,543 | - | 4.8 | 33,914 | Common Stock |
| Desai P. Neil | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 01 Dec 2023 | 8,347 | 1,571,196 | - | 5.1 | 42,881 | Common Stock |
| Desai Neil P. | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 5.15 per share. | 01 Dec 2023 | 10,876 | 1,560,320 | - | 5.1 | 55,986 | Common Stock |
| P. Desai Neil | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 5.02 per share. | 01 Dec 2023 | 15,740 | 1,544,580 | - | 5.0 | 78,941 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 5.20 per share. | 01 Aug 2023 | 19,290 | 1,705,543 | - | 5.2 | 100,250 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 5.22 per share. | 01 Aug 2023 | 22,710 | 1,724,833 | - | 5.2 | 118,523 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 6.55 per share. | 03 Jul 2023 | 16,171 | 1,763,372 | - | 6.5 | 105,873 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 03 Jul 2023 | 10,000 | 1,779,543 | - | 6.6 | 66,446 | Common Stock |
| Neil P. Desai | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 03 Jul 2023 | 15,829 | 1,747,543 | - | 6.3 | 99,273 | Common Stock |
| Richard E. Maroun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Karin M. Hehenberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 28,255 | 28,255 | - | - | Stock Option (right to buy) | |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.19 per share. | 06 Jun 2023 | 7,260 | 1,789,543 | - | 8.2 | 59,453 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.92 per share. | 01 Jun 2023 | 4,982 | 1,826,561 | - | 7.9 | 39,468 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 01 Jun 2023 | 12,443 | 1,814,118 | - | 8.0 | 99,421 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 01 Jun 2023 | 17,315 | 1,796,803 | - | 8.1 | 140,418 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.57 per share. | 04 May 2023 | 2,305 | 1,831,543 | - | 7.6 | 17,445 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 01 May 2023 | 24,479 | 1,849,064 | - | 7.8 | 190,895 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 01 May 2023 | 7,695 | 1,833,848 | - | 7.7 | 59,073 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 01 May 2023 | 7,521 | 1,841,543 | - | 7.5 | 56,225 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 06 Apr 2023 | 12,212 | 1,873,543 | - | 7.1 | 86,616 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.24 per share. | 03 Apr 2023 | 7,336 | 1,885,755 | - | 7.2 | 53,076 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.30 per share. | 03 Apr 2023 | 12,869 | 1,893,091 | - | 7.3 | 93,981 | Common Stock |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.45 per share. | 03 Apr 2023 | 9,583 | 1,905,960 | - | 7.4 | 71,355 | Common Stock |
| Scott Giacobello | CFO, Interim CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Mohammad Hirmand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 59,206 | 59,206 | - | - | Stock Option (right to buy) | |
| Loretta Itri | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 102,350 | 102,350 | - | - | Stock option (right to buy) | |
| Brendan Delaney | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 235,000 | 235,000 | - | - | Stock option (right to buy) | |
| Scott Giacobello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 90,000 | 90,000 | - | - | Stock option (right to buy) | |
| Neil P. Desai | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Brendan Delaney | Director, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 320,000 | 1,849,402 | - | 12.5 | 4,000,000 | Common Stock |
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 240,000 | 499,998 | - | 12.5 | 3,000,000 | Common Stock |
| Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 20,000 | 20,000 | - | 12.5 | 250,000 | Common Stock |
| Scott Giacobello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 26 Sep 2022 | 20,000 | 20,000 | - | 12.5 | 250,000 | Common Stock |
| Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 22 Sep 2022 | 1,260,000 | 3,471,752 | - | 12.5 | 15,750,000 | Common Stock, $0.0001 par value per share ("Common Stock") |
| Richard E. Maroun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Karin M. Hehenberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Behzad Aghazadeh | Director, Ten Percent Owner, See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,573 | 18,573 | - | - | Stock Option (right to buy) | |
| Loretta Itri | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 67,300 | 67,300 | - | - | Stock option (right to buy) | |
| Neil P. Desai | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 153,300 | 153,300 | - | - | Stock option (right to buy) | |
| Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 61,000 | 61,000 | - | - | Stock option (right to buy) | |
| Scott Giacobello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 46,400 | 46,400 | - | - | Stock option (right to buy) | |
| Neil P. Desai | Director, See Remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 18 Mar 2022 | 3,550 | 1,915,543 | - | 20.1 | 71,234 | Common Stock |
| Brendan Delaney | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 260,000 | 260,000 | - | - | Stock option (right to buy) | |
| Neil P. Desai | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2021 | 125,000 | 125,000 | - | - | Stock option (right to buy) | |
| Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2021 | 16,486 | 16,486 | - | - | Stock option (right to buy) | |
| Richard E. Maroun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) | |
| Karin M. Hehenberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) | |
| Anupam Dalal | Director | Purchase of securities on an exchange or from another person at price $ 13.08 per share. | 26 Aug 2021 | 1,529,402 | 1,529,402 | - | 13.1 | 19,999,990 | Common Stock |
| Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) | |
| Caley Castelein | Director | Purchase of securities on an exchange or from another person at price $ 13.08 per share. | 26 Aug 2021 | 259,998 | 259,998 | - | 13.1 | 3,399,994 | Common Stock |
| Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 13.08 per share. | 26 Aug 2021 | 1,911,752 | 2,211,752 | - | 13.1 | 24,999,981 | Common Stock, $0.0001 par value per share ("Common Stock") |
| Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,549 | 17,549 | - | - | Stock option (right to buy) |